DK1094069T4 - DNA kodende for strukturelt protein-1 fra infektiös lakseanæmivirus og anvendelser deraf - Google Patents

DNA kodende for strukturelt protein-1 fra infektiös lakseanæmivirus og anvendelser deraf

Info

Publication number
DK1094069T4
DK1094069T4 DK00203555T DK00203555T DK1094069T4 DK 1094069 T4 DK1094069 T4 DK 1094069T4 DK 00203555 T DK00203555 T DK 00203555T DK 00203555 T DK00203555 T DK 00203555T DK 1094069 T4 DK1094069 T4 DK 1094069T4
Authority
DK
Denmark
Prior art keywords
structural protein
applications
dna encoding
infectious salmon
anemia virus
Prior art date
Application number
DK00203555T
Other languages
Danish (da)
English (en)
Other versions
DK1094069T3 (da
Inventor
Erik Biering
Bjorn Krossoy
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8240749&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1094069(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Application granted granted Critical
Publication of DK1094069T3 publication Critical patent/DK1094069T3/da
Publication of DK1094069T4 publication Critical patent/DK1094069T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK00203555T 1999-10-18 2000-10-12 DNA kodende for strukturelt protein-1 fra infektiös lakseanæmivirus og anvendelser deraf DK1094069T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99203401 1999-10-18

Publications (2)

Publication Number Publication Date
DK1094069T3 DK1094069T3 (da) 2005-05-17
DK1094069T4 true DK1094069T4 (da) 2008-07-21

Family

ID=8240749

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00203555T DK1094069T4 (da) 1999-10-18 2000-10-12 DNA kodende for strukturelt protein-1 fra infektiös lakseanæmivirus og anvendelser deraf

Country Status (10)

Country Link
US (1) US6471964B1 (de)
EP (1) EP1094069B2 (de)
JP (1) JP4777508B2 (de)
AT (1) ATE286507T1 (de)
AU (1) AU778791B2 (de)
CA (1) CA2321437A1 (de)
DE (1) DE60017229D1 (de)
DK (1) DK1094069T4 (de)
NO (1) NO330866B1 (de)
NZ (1) NZ507530A (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60029327T2 (de) * 1999-08-07 2007-07-05 Novartis Ag Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
AU4078401A (en) * 2000-03-08 2001-09-17 University Court Of The University Of Aberdeen, The Viral antigen and vaccine against isav (infectious salmon anaemia virus)
CA2393895A1 (en) * 2001-07-17 2003-01-17 University Of Prince Edward Island Serological test for isav in fish
CA2464338C (en) 2001-10-19 2014-12-02 Akzo Nobel Nv Infectious salmon anaemia virus vaccine
TWI350310B (en) 2002-12-13 2011-10-11 Novartis Ag Immunization of fish with plant-expressed recombinant proteins
WO2008077413A1 (es) 2006-12-22 2008-07-03 Soluciones Biotecnologicas Innovacion Ltda Vacunas adn en peces
EP2482825B1 (de) 2009-10-02 2016-11-23 The Trustees of Columbia University in the City of New York Diagnostische fisch-reoviren-zusammensetzungen
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054476A (en) * 1995-10-18 2000-04-25 Bayer Aktiengesellschaft Iminoacetic acid amides and their use as pest control agents
ES2268719T3 (es) * 1996-11-04 2007-03-16 Ottawa Health Research Institute Procedimiento de expresion de polipeptidos en peces por inmersion en una solucion de plasmidos de adn.
BR9814878A (pt) * 1997-11-21 2000-10-03 Genset Sa Sequência genÈmica e polipeptìdeos de chlamydia pneumoniae, fragmentos dos mesmos e usos dos mesmos, em particular para o diagnóstico, a prevenção e o tratamento de infecção
DE60029327T2 (de) * 1999-08-07 2007-07-05 Novartis Ag Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe

Also Published As

Publication number Publication date
AU778791B2 (en) 2004-12-23
JP2001211888A (ja) 2001-08-07
EP1094069A1 (de) 2001-04-25
CA2321437A1 (en) 2001-04-18
EP1094069B1 (de) 2005-01-05
NO20005217L (no) 2001-04-19
AU6653800A (en) 2001-04-26
DE60017229D1 (de) 2005-02-10
NO330866B1 (no) 2011-08-01
EP1094069B2 (de) 2008-04-23
JP4777508B2 (ja) 2011-09-21
US6471964B1 (en) 2002-10-29
NO20005217D0 (no) 2000-10-17
NZ507530A (en) 2001-08-31
ATE286507T1 (de) 2005-01-15
DK1094069T3 (da) 2005-05-17

Similar Documents

Publication Publication Date Title
CA2005291A1 (en) Feline infectious peritonitis virus diagnostic tools
DK1328543T3 (da) Nukleinsyrer og proteiner fra streptococcus-gruppe A & B
ATE329616T1 (de) Virale nukleotidsequenz vr-2332 und nutzungsverfahren
CY1106513T1 (el) Λεντινοϊικο τριπλο dna και οχηματα και ανασυνδυασμενα κυτταρα που περιεχουν λεντινοϊικο τριπλο dna
ATE257175T1 (de) Rekombinantes infektiöses nicht-in-segmente- geteiltes, negativ-strange-rns-virus
PT1219711E (pt) Vacina de lawsonia intracellularis
DK1094069T3 (da) DNA kodende for strukturelt protein-1 fra infektiös lakseanæmivirus og anvendelser deraf
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
WO2001021807A8 (en) Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
NO885090D0 (no) Polypeptider.
DE60034884D1 (de) Klonierte genome von infektiösen hepatitis c viren genotyp 2a und deren verwendungen
ATE332712T1 (de) Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
WO2001049712A3 (en) Vaccine against isav (infectious salmon anaemia virus)
DE3853693D1 (de) DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung.
NO20041564L (no) Infeksios lakse anemi-virus vaksine
WO2002026784A3 (en) Matrix proteins m1 and m2 of infections salmon anaemia virus
WO2002095413A3 (en) Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia
Zrein et al. Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus
TH98990B (th) ไคเมอริกไวรัสซึ่งแสดงโปรตีนพื้นผิวแบบไม่ใช่โปรตีนธรรมชาติและการใช้ไคเมอริกไวรัสเหล่านี้